Infectious Disease Control

Pfizer and BioNTech Receive Health Sciences Authority Approval for SARS-CoV-2 Sublineage LP.8.1-Adapted Monovalent COVID-19 Vaccine in Singapore

* The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinics inOctober 2025 for individuals 6 months of age and older. SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNT...

2025-10-24 17:33 2121

Wang Qunbin: Innovation-Driven, Fosun's Path to Globalization

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- On 16 October, the 2025 Sustainability Global Leaders Conference was held inShanghai. Themed "Joining Hands to Address Challenges: Global Action, Innovation, and Sustainable Growth", the Conference brought together approximately 500 guests fromChina and ab...

2025-10-17 11:17 3539

With Millions of Children's Lives on the Line, Bill Gates Says Humanity Is at a Crossroads

At 2025 Goalkeepers event, Gates lays out roadmap for saving millions more children's lives by 2045 if governments stretch every dollar and scale a pipeline of affordable, lifesaving innovations Announces new pledge to the Global Fund 2026-2028 replenishment to prevent deaths from AIDS, TB, and ...

2025-09-23 08:00 1971

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tübingen

TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1 billion ( USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and diagnostics for malaria and tuberculosis (TB).2 Investment o...

2025-07-17 10:00 2867

ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO

SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for Paediatric formulations (GAP-f), the World Health Organization (WHO) host network,ziresovir (10mg) has been included in ...

2025-07-16 09:00 4942

SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

SINGAPORE, July 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the Investigation...

2025-07-08 10:02 4083

DoH, USCF and IGI Explore Establishing the World's first-of-their kind Centres for Genome Surgery

On the sidelines of a high-level U.S. visit ABU DHABI, UAE, July 4, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the University of California, San Francisco (UCSF) and the Innovati...

2025-07-04 22:43 4280

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

* Real-time analytics that empower clinical decision-making and pandemic preparedness * Global unveiling at ADLM 2025 in Chicago to initiate business partnerships * Powered by AI and syndromic PCR to enable early detection and predictive insights SEOUL, South Korea, July 1, 2025 /PRNewswire/...

2025-07-01 22:09 5424

8th Asia Dengue Summit Renews Call to Achieve Zero Dengue Deaths, with a Record 14 million Global Cases Reported in 2024

Health leaders, researchers, and advocates unite to advance efforts against dengue through innovation, prevention, and cross-sector collaboration. MANILA, Philippines, June 16, 2025 /PRNewswire/ -- As dengue cases in 2024 double to over 14 million globally, with Asia accounting for 70% of the gl...

2025-06-16 17:35 3425

Uniting for Impact: "United Against Dengue" Collaboration Launches to Elevate Education, Advocacy and Support across Asia

Led by The International Federation of Red Cross and Red Crescent Societies and Takeda, the regional collaboration is dedicated to supporting the World Health Organization (WHO) and ASEAN goal of eliminating preventable dengue deaths by 2030. KUALA LUMPUR, Malaysia, June 12, 2025 /PRNewswire/ --...

2025-06-12 12:40 2737

Gates Foundation Will Double Spending Over Next 20 Years to Accelerate Progress on Saving and Improving Lives

On foundation's 25th anniversary, Bill Gates outlines ambitious goals, inspiration for donating most of his resources and new timeline to spend-down by 2045 SEATTLE, May 8, 2025 /PRNewswire/ -- On the occasion of its 25th year, the Gates Foundation today made a new commitment to accelerate its m...

2025-05-08 20:15 2968

INTREPID Alliance Releases New Report Highlighting Urgent Gaps in Antiviral Preparedness

Global antiviral R&D is slowing when the world can least afford it,  new analysis shows CAMBRIDGE, Mass., May 6, 2025 /PRNewswire/ -- The INTREPID Alliance today released the fourth edition of itsAntiviral Clinical and Preclinical Development Landscape, a comprehensive analysis of the global pi...

2025-05-06 02:16 2695

A global study led by CUHK and the University of Calgary charts four-stage evolution of Inflammatory Bowel Disease

HONG KONG, May 1, 2025 /PRNewswire/ -- An international consortium led by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and the University of Calgary in Canada has conducted a global epidemiological study on Inflammatory Bowel Disease (IBD). It found that this chr...

2025-05-01 15:05 4211

Canada Leads: Canada's No. 1 Hospital Announces Strategy to Attract World's Most Promising Scientists, Drive Health Innovation and Economic Growth

TORONTO, April 8, 2025 /PRNewswire/ -- In a bold move to position Canada as the ultimatedestination for the brightest minds in medical research, whose work will help build our future economy, University Health Network (UHN) is unveiling the ambitiousCanada Leads 100 Challenge to recruit 100 world...

2025-04-08 00:00 3104

Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations

STRASBOURG, France, April 2, 2025 /PRNewswire/ -- To pioneer new frontiers in life science research, the Human Frontier Science Program has awarded 104 of the world's most ingenious scientists from 30 nations with 2025 HFSP Research Grants and the first round of the new Accelerator Grants. 

2025-04-02 08:10 3371

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

FREMONT, Calif., March 19, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established i...

2025-03-19 21:59 4053

Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories

TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1.7 billion ( USD 11.4 million1) in five projects for the development of schistosomiasis diagnostics and drugs for neglected tropical diseases (NTDs).2  ...

2025-03-18 10:42 2217

Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults

* New findings from a recent white paper highlight the economic and healthcare burden posed by Respiratory Syncytial Virus (RSV) on at-risk older adults aged 60 years or over in select high-income APEC countriesand regions, includingAustralia, Hong Kong, Japan, and Singapore * Singapore had 3...

2025-03-11 11:45 2993

Shingles Awareness Week 2025: Shingles increases risk for heart attack and stroke; the disease also increases risk for hospitalisation more than thrice in people with diabetes

* People who have had shingles are at a 59% higher risk for heart attack and at a 35% higher risk for stroke compared to those who have not had shingles. * Adults aged 50 years or over are at high risk for shingles due to age-related decline in immunity and the risk further increases amongst t...

2025-02-26 14:45 2525

Lessons from Japan's AMR Response for the Global Community

https://iris.who.int/handle/10665/380481

2025-02-25 12:00 2109
12345 ... 24